Download
s00401-021-02369-1.pdf 1,73MB
WeightNameValue
1000 Titel
  • GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
1000 Autor/in
  1. Sievers, Philipp |
  2. Stichel, Damian |
  3. Sill, Martin |
  4. Schrimpf, Daniel |
  5. Sturm, Dominik |
  6. Selt, Florian |
  7. Ecker, Jonas |
  8. Kazdal, Daniel |
  9. Miele, Evelina |
  10. Kranendonk, Mariëtte E. G. |
  11. Tops, Bastiaan B. J. |
  12. Kohlhof-Meinecke, Patricia |
  13. Beschorner, Rudi |
  14. Kramm, Christof M. |
  15. Hasselblatt, Martin |
  16. Reifenberger, Guido |
  17. Capper, David |
  18. Wesseling, Pieter |
  19. Stenzinger, Albrecht |
  20. Milde, Till |
  21. Korshunov, Andrey |
  22. Witt, Olaf |
  23. Pfister, Stefan M. |
  24. Wick, Wolfgang |
  25. von Deimling, Andreas |
  26. Jones, David T. W. |
  27. Sahm, Felix |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-18
1000 Erschienen in
1000 Quellenangabe
  • 142(6):1065-1069
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00401-021-02369-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568855/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The genetic basis of brain tumor development is poorly understood. Here, leukocyte DNA of 21 patients from 15 families with ≥ 2 glioma cases each was analyzed by whole-genome or targeted sequencing. As a result, we identified two families with rare germline variants, p.(A592T) or p.(A817V), in the E-cadherin gene CDH1 that co-segregate with the tumor phenotype, consisting primarily of oligodendrogliomas, WHO grade II/III, IDH-mutant, 1p/19q-codeleted (ODs). Rare CDH1 variants, previously shown to predispose to gastric and breast cancer, were significantly overrepresented in these glioma families (13.3%) versus controls (1.7%). In 68 individuals from 28 gastric cancer families with pathogenic CDH1 germline variants, brain tumors, including a pituitary adenoma, were observed in three cases (4.4%), a significantly higher prevalence than in the general population (0.2%). Furthermore, rare CDH1 variants were identified in tumor DNA of 6/99 (6%) ODs. CDH1 expression was detected in undifferentiated and differentiating oligodendroglial cells isolated from rat brain. Functional studies using CRISPR/Cas9-mediated knock-in or stably transfected cell models demonstrated that the identified CDH1 germline variants affect cell membrane expression, cell migration and aggregation. E-cadherin ectodomain containing variant p.(A592T) had an increased intramolecular flexibility in a molecular dynamics simulation model. E-cadherin harboring intracellular variant p.(A817V) showed reduced β-catenin binding resulting in increased cytosolic and nuclear β-catenin levels reverted by treatment with the MAPK interacting serine/threonine kinase 1 inhibitor CGP 57380. Our data provide evidence for a role of deactivating CDH1 variants in the risk and tumorigenesis of neuroepithelial and epithelial brain tumors, particularly ODs, possibly via WNT/β-catenin signaling.
1000 Sacherschließung
lokal Brain Neoplasms/genetics [MeSH]
lokal Golgi Matrix Proteins/genetics [MeSH]
lokal Humans [MeSH]
lokal Oncogene Proteins, Fusion/genetics [MeSH]
lokal Protein-Tyrosine Kinases/genetics [MeSH]
lokal Oncogene Fusion/genetics [MeSH]
lokal Molecular Targeted Therapy [MeSH]
lokal Adaptor Proteins, Signal Transducing/genetics [MeSH]
lokal Glioma/genetics [MeSH]
lokal Pathology
lokal Proto-Oncogene Proteins/genetics [MeSH]
lokal Neurosciences
lokal Correspondence
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3237-6021|https://frl.publisso.de/adhoc/uri/U3RpY2hlbCwgRGFtaWFu|https://frl.publisso.de/adhoc/uri/U2lsbCwgTWFydGlu|https://frl.publisso.de/adhoc/uri/U2NocmltcGYsIERhbmllbA==|https://frl.publisso.de/adhoc/uri/U3R1cm0sIERvbWluaWs=|https://frl.publisso.de/adhoc/uri/U2VsdCwgRmxvcmlhbg==|https://frl.publisso.de/adhoc/uri/RWNrZXIsIEpvbmFz|https://frl.publisso.de/adhoc/uri/S2F6ZGFsLCBEYW5pZWw=|https://frl.publisso.de/adhoc/uri/TWllbGUsIEV2ZWxpbmE=|https://frl.publisso.de/adhoc/uri/S3JhbmVuZG9uaywgTWFyacOrdHRlIEUuIEcu|https://frl.publisso.de/adhoc/uri/VG9wcywgQmFzdGlhYW4gQi4gSi4=|https://frl.publisso.de/adhoc/uri/S29obGhvZi1NZWluZWNrZSwgUGF0cmljaWE=|https://frl.publisso.de/adhoc/uri/QmVzY2hvcm5lciwgUnVkaQ==|https://frl.publisso.de/adhoc/uri/S3JhbW0sIENocmlzdG9mIE0u|https://frl.publisso.de/adhoc/uri/SGFzc2VsYmxhdHQsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/UmVpZmVuYmVyZ2VyLCBHdWlkbw==|https://frl.publisso.de/adhoc/uri/Q2FwcGVyLCBEYXZpZA==|https://frl.publisso.de/adhoc/uri/V2Vzc2VsaW5nLCBQaWV0ZXI=|https://frl.publisso.de/adhoc/uri/U3RlbnppbmdlciwgQWxicmVjaHQ=|https://frl.publisso.de/adhoc/uri/TWlsZGUsIFRpbGw=|https://frl.publisso.de/adhoc/uri/S29yc2h1bm92LCBBbmRyZXk=|https://frl.publisso.de/adhoc/uri/V2l0dCwgT2xhZg==|https://frl.publisso.de/adhoc/uri/UGZpc3RlciwgU3RlZmFuIE0u|https://frl.publisso.de/adhoc/uri/V2ljaywgV29sZmdhbmc=|https://frl.publisso.de/adhoc/uri/dm9uIERlaW1saW5nLCBBbmRyZWFz|https://frl.publisso.de/adhoc/uri/Sm9uZXMsIERhdmlkIFQuIFcu|https://orcid.org/0000-0001-5441-1962
1000 Hinweis
  • DeepGreen-ID: 0a10c857d27f4b579d4cf31337367395 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450690.rdf
1000 Erstellt am 2023-05-11T10:27:27.369+0200
1000 Erstellt von 322
1000 beschreibt frl:6450690
1000 Zuletzt bearbeitet Sat Oct 14 15:31:17 CEST 2023
1000 Objekt bearb. Sat Oct 14 15:31:17 CEST 2023
1000 Vgl. frl:6450690
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450690 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source